Teva Pharmaceutical Industries closes at $7.45 after gaining 1.64%

A quick look at today: after ending yesterday at $7.33, Teva Pharmaceutical Industries Limited spiked to $7.5 today, dropped back to starting point range, and rallied again to $7.45.

• Today's trading volume was 14.16 million shares which is slightly under the 21-day average of 15.65 million.

With investors awaiting market open on the New York Stock Exchange in 3 days, today's session was noteworthy in that Nasdaq climbs 2.19% before ending the session at 12,976. Teva Pharmaceutical Industries climbed to $7.33 with similar gains seen throughout the Healthcare sector (up 2.94%).

The Israeli pharma developer has fallen back around 35.53% from the significant high of $11.37 set 4 months ago. So far this year, it has been under-performing the Nasdaq by 39.6%. Currently, the Israeli pharmaceutical company has a market capitalization of $8.35 billion with an average daily volume of 15.65 million shares.

While Teva Pharmaceutical Industries was bullish today, the following health care stocks underperformed: Medtronic lost 2.49% today and closed at $81.46. Bristol-Myers Squibb Company lost 1.15% today and closed at $63.82. Merck descends 1.1% today to close at $112.3.